JPS629862B2 - - Google Patents

Info

Publication number
JPS629862B2
JPS629862B2 JP2620781A JP2620781A JPS629862B2 JP S629862 B2 JPS629862 B2 JP S629862B2 JP 2620781 A JP2620781 A JP 2620781A JP 2620781 A JP2620781 A JP 2620781A JP S629862 B2 JPS629862 B2 JP S629862B2
Authority
JP
Japan
Prior art keywords
reaction
peroxidase
enzyme
reaction mixture
horseradish peroxidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP2620781A
Other languages
Japanese (ja)
Other versions
JPS56137155A (en
Inventor
Changu Yuan Fu Rojaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JPS56137155A publication Critical patent/JPS56137155A/en
Publication of JPS629862B2 publication Critical patent/JPS629862B2/ja
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase

Description

【発明の詳細な説明】 本発明は酵素免疫試験を行なうのに有用な試剤
および方法に関するものであり、特に過酸化酵素
とその基質との反応生成物の安定化法に関するも
のである。この反応生成物を安定化することによ
つて免疫試剤たとえば抗原、抗体、結合蛋白およ
びハプテン(付着体)の正確な測定が可能となる
のである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to reagents and methods useful for performing enzyme immunoassays, and more particularly to methods for stabilizing the reaction product of peroxidase and its substrate. Stabilization of this reaction product allows for accurate measurements of immunoreagents such as antigens, antibodies, binding proteins, and haptens.

代表的な酵素免疫試験においては、過酸化酵素
(パーオキシダーゼ)のような酵素を免疫試剤
(酵素結合体)に結合させる酵素として反応媒質
中に導入する。酵素でラベルした免疫試剤は試験
反応においてあたかもラベルしていないものの如
く関与する。然しながらその存在は基質を加えて
これを酵素と反応させえられた反応生成物を観察
することによつて検出しうる。反応生成物を正確
に測定するためには、最適点において酵素変性剤
または不可逆的抑制剤たとえばHCl、H2SO4
NaN3またはNaFを導入して酵素−基質反応を停
止することが必要であつた。これらの変性剤は酵
素を破壊することによつて働き、そして化学手段
における潜在的危険性というたゞそれだけの理由
で不満なものである。
In a typical enzyme immunoassay, an enzyme such as peroxidase is introduced into the reaction medium as the enzyme that binds the immunoreagent (enzyme conjugate). Enzyme-labeled immunoreagents participate in test reactions as if they were unlabeled. However, its presence can be detected by adding a substrate and allowing it to react with the enzyme and observing the resulting reaction product. In order to accurately measure the reaction products, enzyme denaturants or irreversible inhibitors such as HCl, H 2 SO 4 ,
It was necessary to introduce NaN3 or NaF to stop the enzyme-substrate reaction. These denaturants work by destroying enzymes and are unsatisfactory solely because of their potential danger in chemical means.

この危険性は、S2O2− およびS2O2− からなる群
からえらばれた還元剤の可溶性塩の安定化量を反
応混合物に導入することを特徴とする電子供与体
たる基質の過酸化酵素との生成物の安定化法を開
発することによつて顕著に消滅させることができ
たのである。
This risk can be reduced by introducing into the reaction mixture a stabilizing amount of a soluble salt of a reducing agent selected from the group consisting of S 2 O 2-5 and S 2 O 2-3 . By developing a method for stabilizing the product with peroxidase, they were able to significantly eliminate it.

第1図は西洋ワサビ過酸化酵素(horseradish
peroxidase:HPO)とo―フエニレンジアミン
(OPD)との反応生成物のナトリウムメタバイサ
ルフアイトおよびナトリウムチオサルフエートに
よる安定化を示すものである。この図からわかる
ように長時間にわたつて均一な光学密度がえられ
る。
Figure 1 shows horseradish peroxidase (horseradish peroxidase).
This figure shows the stabilization of the reaction product of peroxidase (HPO) and o-phenylenediamine (OPD) with sodium metabisulfite and sodium thiosulfate. As can be seen from this figure, uniform optical density can be obtained over a long period of time.

第2図は弱還元剤たるナトリウムアルセナイト
が西洋ワサビ過酸化酵素(HPO)とo―フエニ
レンジアミン(OPD)との反応生成物の安定化
には不適切であることを示している。この図から
わかるように長時間にわたつて光学密度の増加が
認められる。
Figure 2 shows that the weak reducing agent sodium arsenite is unsuitable for stabilizing the reaction product of horseradish peroxidase (HPO) and o-phenylenediamine (OPD). As can be seen from this figure, an increase in optical density is observed over a long period of time.

過酸化酵素特に西洋ワサビ過酸化酵素は少量の
免疫試剤を検出するために酵素免疫試験に広く使
用されている。
Peroxidase, particularly horseradish peroxidase, is widely used in enzyme immunoassays to detect small amounts of immunoreagents.

反応混合物中におけるその存在は次の反応式に
より検出および定量しうる。
Its presence in the reaction mixture can be detected and quantified by the following reaction equation.

酵素―基質反応 (1) 過酸化酵素+H2O2酵素コンプレツクス (2) 酵素コンプレツクス+o―フエニレンジアミ
ン(AH2
〔A〕検出可能生成物+酵素+H2O 安定化反応式 (3) 酵素コンプレツクス+BH2(還元剤)→
B+酵素+H2O (4) H2O+BH2→2H2O+B 検出可能生成物たる化合物Aは分光光度計で測
定しうる黄色化合物である。工程(2)で発生する化
合物の量は存在する過酸化酵素の量と直接に関係
がある。過酸化酵素が免疫試剤に結合するとき、
その化合物の量は酵素−基質反応の強度を検出す
ることによつて試験の任意の相中においてこれを
測定することができる。
Enzyme-substrate reaction (1) Peroxidase + H 2 O 2 enzyme complex (2) Enzyme complex + o-phenylenediamine (AH 2 )
[A] Detectable product + enzyme + H 2 O stabilization reaction formula (3) Enzyme complex + BH 2 (reducing agent) →
B+Enzyme+H 2 O (4) H 2 O+BH 2 →2H 2 O+B The detectable product, Compound A, is a yellow compound that can be measured spectrophotometrically. The amount of compounds generated in step (2) is directly related to the amount of peroxidase present. When peroxidase binds to the immunoreagent,
The amount of the compound can be determined during any phase of the test by detecting the intensity of the enzyme-substrate reaction.

上記反応式によつて発生する検出可能な反応生
成物の量を本発明により正確に測定するために
は、メタバイサルフアイト(S2O2− )またはチオ
サルフエート(S2O2− )のような還元剤を工程(1)
および(2)の後に反応媒質に加えて電子供与体とし
ての基質を置換する。還元剤の還元ポテンシヤル
は評価期間中に反応生成物の濃度を一定レベルに
維持する程度であるべきである。この反応式は工
程(1)および(2)に示され、そして第1図および第2
図に図示されている。
In order to accurately measure the amount of the detectable reaction product generated by the above reaction formula according to the present invention, it is necessary to use metabisulfite (S 2 O 2-5 ) or thiosulfate (S 2 O 2-3 ) . Process reducing agent like (1)
and substituting the substrate as electron donor in addition to the reaction medium after (2). The reduction potential of the reducing agent should be such as to maintain the concentration of reaction products at a constant level during the evaluation period. This reaction equation is shown in steps (1) and (2), and in Figures 1 and 2.
Illustrated in the figure.

次の実施例は本発明の利点を具体的に説明する
ものであるが、本発明の実用性はそこに使用され
ている特定の酵素および基質に制限されるもので
はないことを理解すべきである。たとえば他の過
酸化酵素たとえばラクトパーオキシダーゼ、ベル
ドパーオキシダーゼおよびシトクロムパーオキシ
ダーゼも西洋ワサビ過酸化酵素(ホルセラデイツ
シユパーオキシダーゼ)のように適当であるこ
と、ならびに他の基質たとえばメシジン、ピロガ
ロール、ベンチジン、p―フエニレンジアミン、
2,7―アミノフルオレン、p―トルイジンおよ
びジメチルアラニンもo―フエニレンジアミンの
ように適当であること、が想定される。
Although the following examples illustrate the advantages of the present invention, it should be understood that the utility of the present invention is not limited to the particular enzymes and substrates used therein. be. For example, other peroxidases such as lactoperoxidase, verdoperoxidase and cytochrome peroxidase are also suitable, such as horseradish peroxidase, and other substrates such as mecidine, pyrogallol, benzidine. , p-phenylenediamine,
It is envisaged that 2,7-aminofluorene, p-toluidine and dimethylalanine are also suitable, as is o-phenylenediamine.

実施例 1 H2O2を0.02%およびo―フエニレンジアミン
(OPD)を3mg/ml含むPH5.5のシトレート―ホス
フエート0.1M緩衝液0.3mlに、西洋ワサビ過酸化
酵素約10ngを加えた。反応混合物を室温で30分
間静置した。次いでこの混合物1mlを0.1Mの
Na2S2O3液9mlに加えた。この反応混合物の最大
吸収は450nmであつた。
Example 1 Approximately 10 ng of horseradish peroxidase was added to 0.3 ml of 0.1 M citrate-phosphate buffer at pH 5.5 containing 0.02% H 2 O 2 and 3 mg/ml o-phenylenediamine (OPD). The reaction mixture was allowed to stand at room temperature for 30 minutes. Then 1ml of this mixture was diluted with 0.1M
It was added to 9 ml of Na 2 S 2 O 3 solution. The maximum absorption of this reaction mixture was at 450 nm.

実施例 2 この実施例では30ngの西洋ワサビ過酸化酵素
を実施例1の緩衝液(H2O2−OPD−シトレート
−ホスフエート)6mlに加えた。反応混合物を室
温で30分間静置した。次いでこの反応混合物を、
0.1MのNa2S2O5液9ml、0.5MのNa2S2O5液9mlお
よび0.1Mのシトレート−ホスフエート緩衝液9
mlを含むチユーブに加えた。えられた結果はメタ
バイサルフアイト溶液が少なくとも5時間にわた
つて検出可能な反応生成物を安定化したことを示
している。シトレート緩衝液中の活性化コンプレ
ツクスの吸光度は1時間以内に2倍増加した。
Example 2 In this example, 30 ng of horseradish peroxidase was added to 6 ml of the buffer of Example 1 ( H2O2 -OPD -citrate-phosphate). The reaction mixture was allowed to stand at room temperature for 30 minutes. This reaction mixture was then
9 ml of 0.1 M Na 2 S 2 O 5 solution, 9 ml of 0.5 M Na 2 S 2 O 5 solution and 9 ml of 0.1 M citrate-phosphate buffer
Added to tube containing ml. The results obtained show that the metabisulfite solution stabilized the detectable reaction products for at least 5 hours. The absorbance of activated complexes in citrate buffer increased 2-fold within 1 hour.

実施例 3 100ngの西洋ワサビ過酸化酵素を、実施例1の
緩衝液(H2O2−OPD−シトレート−ホスフエー
ト)各1mlを含む3本のチユーブに加えた。反応
混合物を室温に30分間保持した。反応を停止する
ため、Na2S2O5の0.01M、0.05Mおよび0.1M溶液
の5mlを反応チユーブのそれぞれに加えた。反応
混合物を450nmにおいて24時間検査した。えられ
た結果は、0.05MのNa2S2O5溶液はこの期間中反
応物から安定化したが0.01Mの溶液は十分に強い
還元剤ではなかつた、ことを示した。
Example 3 100 ng of horseradish peroxidase was added to three tubes each containing 1 ml of the buffer of Example 1 ( H2O2 -OPD -citrate-phosphate). The reaction mixture was kept at room temperature for 30 minutes. To stop the reaction, 5 ml of 0.01M, 0.05M and 0.1M solutions of Na2S2O5 were added to each of the reaction tubes. The reaction mixture was examined at 450 nm for 24 hours. The results obtained showed that the 0.05M Na 2 S 2 O 5 solution stabilized from the reactants during this period, but the 0.01M solution was not a strong enough reducing agent.

実施例 4 上述のH2O2―OPD―シトレート―ホスフエー
ト緩衝液に4ngのHPOを加えた。反応混合物を室
温に5分間保持した。停止時に0.3mlの反応混合
物を、0.1M―Na3AsO3、0.1M―Na2S2O5、0.1M
―KIおよび0.1M―Na2S2O3の各1mlをそれぞれ
含む4本のチユーブに加えた。混合物の吸収スペ
クトルを450nmにおいて22時間検査した。
Example 4 4 ng of HPO was added to the H2O2 - OPD -citrate-phosphate buffer described above. The reaction mixture was kept at room temperature for 5 minutes. Upon stopping, add 0.3 ml of the reaction mixture to 0.1 M—Na 3 AsO 3 , 0.1 M—Na 2 S 2 O 5 , 0.1 M
-KI and 0.1M-Na 2 S 2 O 3 were added to 4 tubes each containing 1 ml each. The absorption spectrum of the mixture was examined at 450 nm for 22 hours.

えられた結果は、Na2S2O3およびNa2S2O5のい
づれも活性化コンプレツクスを安定化したことを
示した。沃化カリウムは発生するI2が450nmにお
ける測定を妨害するので不適切であつた。
Na2AsO3は時間の経過と共に着色強度が増大する
ので明らかに十分な還元剤ではなかつた。
The results obtained showed that both Na 2 S 2 O 3 and Na 2 S 2 O 5 stabilized the activated complex. Potassium iodide was unsuitable because the I 2 generated interfered with measurements at 450 nm.
Na 2 AsO 3 was clearly not a sufficient reducing agent as the color intensity increased over time.

実施例 5 反応トレイ中のHBcAg(ヘパテイテイス―B
コア抗原)予備被覆ポリスチレンビーヅに、抗
HBc(抗ヘパテイテイス―Bコア)陽性サンプル
の滅菌稀釈液0.2mlを加えた。この免疫試剤を45
℃で2時間反応させた。反応物からビーヅを除
き、水5mlで2回洗つた。洗浄ビーヅに抗HBc:
HRP結合体0.2mlを加えた。このビーヅおよびラ
ベルした結合体を45℃で1時間放置した。反応物
からビーヅを再び除き、水5mlで4回洗い、
H2O2―OPD―シトレート―ホスフエート緩衝液
0.3mlを含む反応チユーブに移した。室温に30分
間置いた後、0.1M―Na2S2O51mlを加えて反応を
停止し、二元波長分析器により45nmにおいて吸
収スペクトルを測定した。えられた滴定カーブは
Na2S2O5が免液試験環境に使用するに適するもの
であることを示した。
Example 5 HBcAg (Hepatiteis-B) in the reaction tray
core antigen) pre-coated polystyrene beads,
0.2 ml of a sterile dilution of an HBc (anti-hepatitis-B core) positive sample was added. 45% of this immunoreagent
The reaction was carried out at ℃ for 2 hours. The beads were removed from the reaction mixture and washed twice with 5 ml of water. Anti-HBc to washed bead:
0.2 ml of HRP conjugate was added. The beads and labeled conjugate were left at 45°C for 1 hour. Remove the beads from the reaction mixture again and wash with 5 ml of water 4 times.
H 2 O 2 - OPD - Citrate - Phosphate Buffer
Transferred to a reaction tube containing 0.3 ml. After standing at room temperature for 30 minutes, 1 ml of 0.1M-Na 2 S 2 O was added to stop the reaction, and the absorption spectrum was measured at 45 nm using a dual wavelength analyzer. The obtained titration curve is
It has been shown that Na 2 S 2 O 5 is suitable for use in a liquid immunity test environment.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は西洋ワサビ過酸化酵素(horseradish
peroxidase:HPO)とo―フエニレンジアミン
(OPD)との反応生成物に及ぼす本発明のナトリ
ウムメタバイサルフアイトおよびナトリウムチオ
サルフエートによる安定化効果を示すものであ
る。第2図はHPOとOPDとの反応生成物に及ぼ
す本発明のナトリウムメタバイサルフアイトによ
る安定化効果を安定化剤を含まないシトレート―
フオフエート緩衝液および安定化剤としてナトリ
ウムアルセナイトを含む緩衝液との対比において
示すものである。第1図および第2図において横
軸は経過時間(単位時間)を縦軸は450nmにおけ
る光学密度をそれぞれ示す。 〓〓〓……ナトリウムメタバイサルフアイトの
カーブ、〓〓〓……ナトリウムチオサルフエート
のカーブ、〓〓〓……安定化剤を含まない緩衝液
のカーブ、〓〓〓……安定化剤としてナトリウム
アルセナイトを含む緩衝液のカーブ、〓〓〓……
安定剤としてナトリウムメタバイサルフアイトを
含む緩衝液のカーブ。
Figure 1 shows horseradish peroxidase (horseradish peroxidase).
1 shows the stabilizing effect of sodium metabisulfite and sodium thiosulfate of the present invention on the reaction product of peroxidase (HPO) and o-phenylenediamine (OPD). Figure 2 shows the stabilizing effect of sodium metabisulfite of the present invention on the reaction product of HPO and OPD with citrate containing no stabilizer.
It is shown in comparison with a phosphate buffer and a buffer containing sodium arsenite as a stabilizer. In FIGS. 1 and 2, the horizontal axis represents elapsed time (unit time), and the vertical axis represents optical density at 450 nm. 〓〓〓...Curve of sodium metabisulfite, 〓〓〓...Curve of sodium thiosulfate, 〓〓〓...Curve of buffer without stabilizer, 〓〓〓...Sodium as stabilizer Curve of buffer solution containing arsenite,〓〓〓……
Curve for a buffer containing sodium metabisulfite as a stabilizer.

Claims (1)

【特許請求の範囲】 1 電子供与体と過酸化酵素との反応混合物に
S2O2− およびS2O2− からなる群からえらばれた還
元剤の可溶性塩を添加することを特徴とする電子
供与体たる基質と過酸化酵素との反応生成物の安
定化法。 2 酵素が西洋ワサビ過酸化酵素である特許請求
の範囲第1項記載の方法。 3 還元性塩がNa2S2O5である特許請求の範囲第
1項記載の方法。 4 還元性塩がNa2S2O3である特許請求の範囲第
1項記載の方法。 5 基質がo―フエニレンジアミンである特許請
求の範囲第1項記載の方法。 6 o―フエニレンジアミンと西洋ワサビ過酸化
酵素との反応生成物の安定化法である特許請求の
範囲第1項記載の方法。 7 還元性塩がNa2S2O5である特許請求の範囲第
6項記載の方法。 8 還元性塩がNa2S2O3である特許請求の範囲第
6項記載の方法。
[Claims] 1. In a reaction mixture of an electron donor and a peroxidase
Stabilization of the reaction product of a peroxidase with a substrate as an electron donor, characterized by adding a soluble salt of a reducing agent selected from the group consisting of S 2 O 2-5 and S 2 O 2-3 Law. 2. The method according to claim 1, wherein the enzyme is horseradish peroxidase. 3. The method according to claim 1, wherein the reducing salt is Na 2 S 2 O 5 . 4. The method according to claim 1, wherein the reducing salt is Na 2 S 2 O 3 . 5. The method according to claim 1, wherein the substrate is o-phenylenediamine. 6. The method according to claim 1, which is a method for stabilizing a reaction product of o-phenylenediamine and horseradish peroxidase. 7. The method according to claim 6, wherein the reducing salt is Na 2 S 2 O 5 . 8. The method according to claim 6, wherein the reducing salt is Na 2 S 2 O 3 .
JP2620781A 1980-03-03 1981-02-26 Stabilization of resultant detectable generated during immunity test of enzime Granted JPS56137155A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12681780A 1980-03-03 1980-03-03

Publications (2)

Publication Number Publication Date
JPS56137155A JPS56137155A (en) 1981-10-26
JPS629862B2 true JPS629862B2 (en) 1987-03-03

Family

ID=22426850

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2620781A Granted JPS56137155A (en) 1980-03-03 1981-02-26 Stabilization of resultant detectable generated during immunity test of enzime

Country Status (5)

Country Link
JP (1) JPS56137155A (en)
BE (1) BE887771A (en)
DE (1) DE3107904A1 (en)
FR (1) FR2477176A1 (en)
GB (1) GB2070767B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258329A (en) * 1987-04-13 1988-10-25 Taitoo:Kk Card issuing device
JPH01135573U (en) * 1988-03-10 1989-09-18
JPH0358761U (en) * 1989-10-16 1991-06-07

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59500252A (en) * 1982-03-03 1984-02-23 ブリティッシュ・テクノロジー・グループ・リミテッド Enhanced luminescence and emission spectroscopy
US5225325A (en) * 1990-03-02 1993-07-06 Ventana Medical Systems, Inc. Immunohistochemical staining method and reagents therefor
GB9723773D0 (en) 1997-11-12 1998-01-07 Univ Glasgow Haptoglobin assay
GB9924180D0 (en) * 1999-10-12 1999-12-15 Univ Glasgow Assays for mastitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6608106A (en) * 1966-06-10 1967-12-11
NL7610608A (en) * 1976-09-24 1978-03-29 Akzo Nv PROCESS FOR STABILIZING PEROXIDASE-CONTAINING COMPOSITIONS.
US4234680A (en) * 1979-08-03 1980-11-18 Calbiochem-Behring Corp. Method for terminating a peroxidase catalyzed reaction
US4252896A (en) * 1980-01-07 1981-02-24 Abbott Laboratories Method of stabilizing peroxidase in a serum protein based medium

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258329A (en) * 1987-04-13 1988-10-25 Taitoo:Kk Card issuing device
JPH01135573U (en) * 1988-03-10 1989-09-18
JPH0358761U (en) * 1989-10-16 1991-06-07

Also Published As

Publication number Publication date
FR2477176A1 (en) 1981-09-04
JPS56137155A (en) 1981-10-26
FR2477176B1 (en) 1984-09-14
BE887771A (en) 1981-09-03
DE3107904A1 (en) 1982-01-21
GB2070767A (en) 1981-09-09
GB2070767B (en) 1983-07-27

Similar Documents

Publication Publication Date Title
Vogels et al. Differential analyses of glyoxylate derivatives
CA1155737A (en) Process and diagnostic agents for the detection of redox reactions
CA1252713A (en) Instrumentless quantitative analysis system
Gilbert et al. Spectrophotometric determination of methyl glyoxal with 2, 4-dinitrophenylhydrazine
JPS629862B2 (en)
EP1038939B1 (en) Chemiluminescent reagents and chemiluminescence analysis methods with the use of the same
EP0198286A2 (en) Analytical compositions, elements and methods utilizing reduction of ferric ion chelates to form detectable dyes
JPS584918B2 (en) Method for measuring glutamate-oxaloacetate-transaminase and glutamate-pyruvate-transaminase
US4302537A (en) Reagent and method for the determination of peroxidase
JP4319545B2 (en) Total cysteine assay
Chen et al. Ambivalent active-site-directed inactivators of liver alcohol dehydrogenase
Hatase et al. Specific inhibition of phosphate transport in mitochondria by N-ethylmaleimide
JPS6342470A (en) Method for measuring peroxidase or h2o2
JPS6252466A (en) Method and reagent measuring immunity reaction component
EP0348144B1 (en) Method for treating mucus-containing immunoassay samples
JP4120024B2 (en) Improved enzyme substrate
JPH012598A (en) How to measure calcium
JPS58220696A (en) Measurement of activity of glutamate- oxaroacetate-transamynase, analytic reagent and analytic test piece therefor
JPH052942B2 (en)
JPS62180269A (en) Enzyme immunological measuring method for free thyroxine
JPS62218865A (en) Quantitative analysis of rheumatic factor
JPH01153962A (en) Assay of thyroid hormone and reagent system used therefor
JPS6058095A (en) Determination of free fatty acid in serum
JP3804102B2 (en) Improved process for producing enzyme substrates
JPS60178354A (en) Stable color forming composition